Online citations, reference lists, and bibliographies.
← Back to Search

Protein-Nanoparticle Interactions

M. Rahman, S. Laurent, N. Tawil, L. Yahia, M. Mahmoudi
Published 2013 · Chemistry

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
In the recent decade, the fabrication of nanoparticles and exploration of their properties have attracted the attention of all branches of science such as physicists, chemists, biologists, engineers, and even medical doctors. Interests for nanoparticles arise from the fact that their mechanical, chemical, electrical, optical, magnetic, electro-optical, and magneto-optical properties of these nanoparticles are completely different from their bulk properties and the predetermined differences are depended on the physicochemical properties of the nanoparticles. There are numerous areas where nanoparticles are of scientific and technological interest, specifically for medical community, where the synthetic and biologic worlds come together and lead to an important concern for design of safe nano-biomaterials. In this chapter, we review and discuss the major biomedical applications of nanoparticles. 1.1 Nanoscience in Medicine Nanomedicine is the application of nanosciences to health and exploits the physical, chemical, and biological properties of nanomaterials. The advent of nanoscience and nanotechnologies is shaping the face of industrial production and economics. As a matter of fact, nano-based products now include electronic components, paint, sports equipment, fabrics, sunscreens, and other cosmetics [1]. However, the most exciting nano-innovations reside in the conception of new medical products such as heart valves, drug-delivery systems, and imaging techniques [1], which will surely obliterate the long-established boundaries amidst chemistry, physics, and biology. It is anticipated that nanotechnology will have substantial economic impacts by encouraging productivity and competitiveness, converging different disciplines of science and technologies, and stimulating education and human development [2]. Experts predict market growth to hundreds of billions of dollars in the next decade. The worldwide market for products exploiting nanotechnology reached M. Rahman et al., Protein-Nanoparticle Interactions, Springer Series in Biophysics 15, DOI 10.1007/978-3-642-37555-2_1, © Springer-Verlag Berlin Heidelberg 2013 1 about US$254 billion in 2009, with nanomedical products accounting for a margin of US$72.8 billion in 2011 [3]. The US government has granted more than US$20 billion to the US National Nanotechnology Initiative for nanotechnology research and development activities, facilities, and workforce training since 2000 [4]. In 2011, the Canadian Institutes of Health Research (CIHR) and the Canadian Space Agency (CSA) have granted US $16 million in funding to seven new research projects on regenerative medicine and nanomedicine [5]. The European Framework Program [6] will invest about 600 million euros per year for nanotechnology research until 2013, with a supplementary, comparable sum provided by individual countries [7]. The economic landscape is thus being dramatically altered by nanotechnology. For instance, in 2004, worldwide corporations spent US$3.8 billion on research and development [8]. More importantly, there is a shift from the discovery stage to applications on nanotechnology, as demonstrated by the ratio increased corporate patent applications to scientific publications from 0.23 in 1999 to 1.2 in 2008 [2]. Additionally, analysts estimate that by 2014, nanotechnology will be responsible for 15 % of all manufactured merchandise, valuing approximately US$2.6 trillion and will create 10 million jobs globally [1]. Physicochemical properties of nanoparticles such as their small size, large surface area, and kinetics of adsorption make them particularly interesting as tools for molecular diagnostics, in vivo imaging, and improved treatment of disease. Metal oxides have been introduced in the early 1960s as ferromagnetic separation moieties and have brought about the use of nanoparticles for magnetic resonance imaging (MRI) in the late 1970s. More recently, application of nanoparticles to medicine has expanded to cellular therapy [9], tissue repair [10], drug delivery [11], hyperthermia [12], (MRI) [13], magnetic resonance spectroscopy [14], magnetic separation [15], and as sensors for metabolites and other biomolecule [16]. Moreover, the unique magnetic properties and small size of magnetic nanoparticles (MNPs) make them appealing for biomolecule labeling in bioassays, as well as MRI contrast agents [17]. Superparamagnetic iron oxide (SPIO) can also be used as magnetic gradients for cell sorting in bioreactors [18], as well as absorbing material in radio-frequency hyperthermia. Moreover, the exceptional physical, mechanical, and electronic properties of carbon nanotubes (CNTs) allow them to be used as biosensors, probes, actuators, nanoelectronic devices, drug-delivery systems, and tissue-repair scaffolds within biomedical applications [19–21]. Recent research has focused on conjugating nanocarriers to specific ligands such as peptides, antibodies, and small molecules and subsequently directing them to sites of interest [22]. These techniques can prove to be appealing alternatives for current cancer and cardiovascular applications. Thus, a vast array of nanotechnologies can be applied to medical devices, materials, and processes that will affect the prevention, early diagnosis, and treatment of diseases. However, the risk–benefit balance for these materials, with regard to their toxicological profile and any potential adverse pathogenic reactions from exposure, will ultimately define their clinical outcome. 2 1 The Biological Significance of “Nano”-interactions
This paper references
10.1016/0378-5173(87)90034-2
Murine plasma fibronectin depletion after intravenous injection of liposomes
H. Schreier (1987)
10.1002/JBM.820260403
Albumin-binding surfaces for implantable devices.
J. R. Keogh (1992)
10.1074/jbc.270.43.25845
β2-Glycoprotein I Is a Major Protein Associated with Very Rapidly Cleared Liposomes in Vivo, Suggesting a Significant Role in the Immune Clearance of "Non-self" Particles (*)
A. Chonn (1995)
10.1016/0169-409X(95)00022-Y
Which polymers can make nanoparticulate drug carriers long-circulating?
V. Torchilin (1995)
10.1002/JMRI.1880070629
Uptake of dextran‐coated monocrystalline iron oxides in tumor cells and macrophages
A. Moore (1997)
10.1016/S0927-7765(99)00156-3
'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption.
Gref (2000)
Long-circulating and target-specific nanoparticles: theory to practice.
S. Moghimi (2001)
10.1016/S0005-2736(01)00330-3
Protein adsorption to polyethylene glycol modified liposomes from fibrinogen solution and from plasma.
M. E. Price (2001)
10.1038/nrc1146
Caveolae: mining little caves for new cancer targets
Lucy A. Carver (2003)
10.1016/S0169-409X(02)00228-4
Biodegradable nanoparticles for drug and gene delivery to cells and tissue.
J. Panyam (2003)
10.1016/J.TOX.2005.07.023
Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity.
J. Szebeni (2005)
10.1016/J.BBRC.2004.12.137
The role of apolipoprotein E in the elimination of liposomes from blood by hepatocytes in the mouse.
Xuedong Yan (2005)
10.1080/10611860500071292
Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: Comparison of plasma protein adsorption patterns
T. Göppert (2005)
10.1038/sj.bjp.0706386
Nanoparticle‐induced platelet aggregation and vascular thrombosis
Anna Radomski (2005)
10.1016/J.EJPB.2005.02.006
Protein adsorption patterns on poloxamer- and poloxamine-stabilized solid lipid nanoparticles (SLN).
T. Göppert (2005)
10.1126/SCIENCE.1127085
Proteasome-Independent Functions of Ubiquitin in Endocytosis and Signaling
D. Mukhopadhyay (2007)
10.1016/S1387-2656(07)13012-X
Using nanotechnology to improve the characteristics of antineoplastic drugs: improved characteristics of nab-paclitaxel compared with solvent-based paclitaxel.
M. Foote (2007)
10.1002/ELPS.200600694
Analysis of plasma protein adsorption onto PEGylated nanoparticles by complementary methods: 2‐DE, CE and Protein Lab‐on‐chip® system
H. R. Kim (2007)
10.1038/nnano.2007.223
Immunological properties of engineered nanomaterials
M. Dobrovolskaia (2007)
10.1166/JNN.2007.330
Effects of hydrated forms of C60 fullerene on amyloid 1-peptide fibrillization in vitro and performance of the cognitive task.
I. Y. Podolski (2007)
10.1093/TOXSCI/KFM217
Adsorbed proteins influence the biological activity and molecular targeting of nanomaterials.
D. Dutta (2007)
10.1016/j.biomaterials.2008.09.050
The influence of protein adsorption on nanoparticle association with cultured endothelial cells.
Morton Ehrenberg (2009)
10.1016/j.addr.2009.03.009
Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy.
Parag Aggarwal (2009)
10.1021/am9005463
Complement activation by polymers carrying hydroxyl groups.
Yoshio Arima (2009)
10.1038/nrm2652
New roles for endosomes: from vesicular carriers to multi-purpose platforms
G. Gould (2009)
10.1002/CHIN.201034225
Testing Metal‐Oxide Nanomaterials for Human Safety
R. Landsiedel (2010)
10.1021/cr100440g
Protein-nanoparticle interactions: opportunities and challenges.
M. Mahmoudi (2011)
10.1021/ja107583h
Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles.
M. Monopoli (2011)
10.1517/17425247.2011.554818
Interactions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systems
P. Karmali (2011)
10.1038/nchem.1090
Exploring and exploiting chemistry at the cell surface.
M. Mager (2011)
10.1021/nn2021088
Toxicity evaluations of superparamagnetic iron oxide nanoparticles: cell "vision" versus physicochemical properties of nanoparticles.
M. Mahmoudi (2011)
Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of cancer.
S. Laurent (2011)
10.1016/j.biomaterials.2011.08.048
The effects of aggregation and protein corona on the cellular internalization of iron oxide nanoparticles.
M. Safi (2011)
10.1021/nn202458g
The evolution of the protein corona around nanoparticles: a test study.
M. Lundqvist (2011)
Cancer cell targeting of lipid gene vectors by protein corona
G. Caracciolo (2012)
10.1021/cr2002596
Assessing the in vitro and in vivo toxicity of superparamagnetic iron oxide nanoparticles.
M. Mahmoudi (2012)
10.1371/journal.pone.0029997
Crucial Ignored Parameters on Nanotoxicology: The Importance of Toxicity Assay Modifications and “Cell Vision”
S. Laurent (2012)
10.1039/c2nr31185b
Cell "vision": complementary factor of protein corona in nanotoxicology.
M. Mahmoudi (2012)
10.1016/j.jconrel.2012.04.009
Designing the nanoparticle-biomolecule interface for "targeting and therapeutic delivery".
E. Mahon (2012)
10.1039/C2RA01374F
Interdisciplinary challenges and promising theranostic effects of nanoscience in Alzheimer's disease
S. Laurent (2012)
10.1039/c3cc37307j
Protein corona significantly reduces active targeting yield.
Vahid Mirshafiee (2013)
10.1038/nnano.2012.237
Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface.
A. Salvati (2013)
10.1021/cn300205g
Physiological temperature has a crucial role in amyloid β in the absence and presence of hydrophobic and hydrophilic nanoparticles.
Mahdi Ghavami (2013)



This paper is referenced by
10.7150/thno.47446
Collagenase IV and clusterin-modified polycaprolactone-polyethylene glycol nanoparticles for penetrating dense tumor tissues
Hao-Yan Huang (2021)
10.2147/IJN.S304902
The Anti-Proliferative Activity of Coordination Compound-Based ZnO Nanoparticles as a Promising Agent Against Triple Negative Breast Cancer Cells
Hana Štěpánková (2021)
10.1186/s12951-021-00896-3
Protein nanoparticles in drug delivery: animal protein, plant proteins and protein cages, albumin nanoparticles
E. Kianfar (2021)
A Combo Compound Therapy Effectively Reduces SARS-CoV-1 Viral Load in Mouse Lung
J. Tunac (2021)
10.1016/J.MTCOMM.2021.102172
Does the nanoparticle morphology influence interaction with protein: a case study with hydroxyapatite nanoparticles
Kavita Kadu (2021)
10.1021/acsomega.1c00310
Green Synthesis of Zinc Oxide (ZnO) Nanoparticles Using Aqueous Fruit Extracts of Myristica fragrans: Their Characterizations and Biological and Environmental Applications
S. Faisal (2021)
10.1007/s11356-021-12924-8
Estimates of lung burden risk associated with long-term exposure to TiO2 nanoparticles as a UV-filter in sprays
W. Wang (2021)
10.3390/nano11030561
Protein Adsorption on SiO2-CaO Bioactive Glass Nanoparticles with Controllable Ca Content
Martin Kapp (2021)
10.1021/acsomega.1c01789
Adsorption–Reaction Processes Between Gelatin and PDMS-E Emulsion Droplets
Huijun Ma (2021)
10.3390/ijms22030989
Green Synthesis of Selenium and Tellurium Nanoparticles: Current Trends, Biological Properties and Biomedical Applications
Marjorie C Zambonino (2021)
10.1186/s12951-021-00824-5
A DM1-doped porous gold nanoshell system for NIR accelerated redox-responsive release and triple modal imaging guided photothermal synergistic chemotherapy
Pengcheng Xu (2021)
Nanocarriers for the Oral Delivery of Drugs With Special Focus on Porous Silicon: A Review
Asad Muhammad Azama (2021)
10.1002/PPSC.202100016
Nanoparticle Tracking Analysis of Polymer Nanoparticles in Blood Plasma
Mark S. Bannon (2021)
10.1007/s12145-021-00646-x
WebFPTI: A tool to predict the toxicity/pathogenicity of mineral fibres including asbestos
Alessandro F. Gualtieri (2021)
10.1039/c9na00537d
Isolation methods for particle protein corona complexes from protein-rich matrices
Linda Böhmert (2020)
10.1109/OJEMB.2020.2989468
Assessment of Superparamagnetic Iron Oxide Nanoparticle Poly(Ethylene Glycol) Coatings on Magnetic Resonance Relaxation for Early Disease Detection
Cari L. Meisel (2020)
10.1007/s13346-020-00745-0
Unveiling the pitfalls of the protein corona of polymeric drug nanocarriers
Germán Berrecoso (2020)
10.1016/j.heliyon.2020.e04053
Enhanced catalytic activity of Bacillus aryabhattai P1 protease by modulation with nanoactivator
A. Pathak (2020)
10.1080/24701556.2020.1870496
Curcumin reduced gold nanoparticles synergistically induces ROS mediated apoptosis in MCF-7 cancer cells
Sindhu Kondath (2020)
10.1016/j.yrtph.2020.104611
The SCCS guidance on the safety assessment of nanomaterials in cosmetics.
U. Bernauer (2020)
10.1021/acsomega.9b02988
Probing Nanoparticle–Cell Interaction Using Micro-Raman Spectroscopy: Silver and Gold Nanoparticle-Induced Stress Effects on Optically Trapped Live Red Blood Cells
S. Barkur (2020)
10.1002/btpr.3051
Promising insights into the kosmotropic effect of magnetic nanoparticles on proteins: The pivotal role of protein corona formation
Reza Fattah (2020)
10.1039/c9en00938h
The rise of the nanomaterial metabolite corona, and emergence of the complete corona
Andrew J Chetwynd (2020)
10.3390/nano10112255
Transformation and Cytotoxicity of Surface-Modified Silver Nanoparticles Undergoing Long-Term Aging
Chengfang Pang (2020)
10.1038/s41598-020-71170-z
Human plasma protein corona decreases the toxicity of pillar-layer metal organic framework
S. Jafari (2020)
10.3390/ijms21249734
Exploring the Conformation and Thermal Stability of Human Serum Albumin Corona of Ferrihydrite Nanoparticles
C. Chilom (2020)
Insights into gold nanoparticles functionalized with cysteine-terminated cecropin melittin and cathelicidin-derived antimicrobial peptides - a computational approach
André Filipe Simões Ferreira (2020)
10.2147/IJN.S250001
A Review on the Biodistribution, Pharmacokinetics and Toxicity of Bismuth-Based Nanomaterials
Samireh Badrigilan (2020)
Kako proteinska korona određuje sudbinu nanočestica u biološkom okolišu
Šupraha Goreta (2020)
10.1021/acs.langmuir.0c01334
From Protein Corona to Colloidal Self-Assembly: The Importance of Protein Size in Protein-Nanoparticle Interactions.
L. Marichal (2020)
10.2147/IJN.S254808
Protein–Nanoparticle Interaction: Corona Formation and Conformational Changes in Proteins on Nanoparticles
Sung Kyeong Park (2020)
10.1039/d0na00231c
The protein corona determines the cytotoxicity of nanodiamonds: implications of corona formation and its remodelling on nanodiamond applications in biomedical imaging and drug delivery
D. Khanal (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar